Login / Signup

Biomarkers That Predict an Unclear Benefit From Adjuvant Trastuzumab, Pertuzumab and Pembrolizumab When Those Same Drugs Were Given Neoadjuvantly.

Steven Mark Sorscher
Published in: Journal of breast cancer (2022)
Keyphrases
  • epidermal growth factor receptor
  • advanced non small cell lung cancer
  • metastatic breast cancer
  • early stage
  • tyrosine kinase
  • drug induced